HMGN3 Activators are a set of chemical compounds that indirectly augment the functional activity of HMGN3 through a cascade of intracellular signaling pathways, leading to phosphorylation and enhanced chromatin interactions. Compounds like Forskolin and IBMX work to increase intracellular cAMP levels, indirectly enhancing HMGN3's role in chromatin remodeling by activating PKA, which can then phosphorylate HMGN3. Similarly, the cAMP analogue 8-Br-cAMP and the phosphodiesterase inhibitor Rolipram elevate PKA activity, potentially increasing HMGN3 phosphorylation and function. The activation of protein kinase C through PMA and the elevation of intracellular calcium levels by ionophores A-23187 and Ionomycin are thought to lead to the activation of kinases that may phosphorylate HMGN3, thereby enhancing its interaction with nucleosomes and promoting its chromatin remodeling activity.
Additionally, EGCG's kinase inhibition may shift the phosphorylation equilibrium in the cell, possibly favoring HMGN3's enhanced chromatin interaction. The L-type calcium channel agonist Bay K8644 raises intracellular calcium levels, which could activate calcium-dependent kinases to phosphorylate HMGN3 and boost its chromatin remodeling role. The actions of Zaprinast and the phosphodiesterase inhibitor Vinpocetine further support the elevation of cAMP and subsequent PKA activity, which is likely to increase HMGN3's functional activity. Although H-89 is primarily known as a PKA inhibitor, its broader influence on kinase activity could lead to a favorable alteration in the phosphorylation and activity of HMGN3.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, increasing cAMP levels. Elevated cAMP enhances the activity of PKA, which can phosphorylate HMGN3, potentially increasing its DNA-binding affinity and promoting chromatin remodeling functions. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) prevents the degradation of cAMP by inhibiting phosphodiesterases, leading to higher PKA activity. PKA may then phosphorylate HMGN3, enhancing its interaction with nucleosomes. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which may phosphorylate and alter the function of proteins associated with chromatin structure, potentially increasing the activity of HMGN3 in chromatin remodeling. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A-23187 acts as a calcium ionophore, increasing intracellular calcium levels, which can activate calcium-dependent protein kinases that might phosphorylate HMGN3, thereby enhancing its role in chromatin remodeling. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is another calcium ionophore that raises intracellular calcium concentration, activating calmodulin-dependent kinases, which could indirectly enhance HMGN3 function by promoting its phosphorylation and chromatin interaction. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cAMP analogue that activates PKA. PKA activation could enhance HMGN3's chromatin remodeling activity through increased phosphorylation. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase 4, leading to an increase in cAMP levels. This elevation can enhance PKA activity, which may indirectly increase HMGN3's functional activity by promoting phosphorylation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG has been found to inhibit several protein kinases, potentially leading to a shift in the phosphorylation balance within the cell that could favor HMGN3's enhanced activity in chromatin remodeling and interaction with other proteins. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
Bay K8644 acts as an L-type calcium channel agonist, increasing intracellular calcium levels. This can activate calcium-dependent kinases which may phosphorylate HMGN3, thus enhancing its chromatin remodeling activities. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits phosphodiesterase 5, increasing cAMP levels in cells. This can lead to elevated PKA activity, potentially enhancing the phosphorylation and function of HMGN3 in chromatin structure modulation. | ||||||